Form 4: Sotera Health Co: Executive Michael Rutz Reports Stock Transactions

Michael Rutz, President of Sterigenics at Sotera Health Co, reports acquisition and disposal of common stock and restricted stock units (RSUs) related to tax obligations and new grants.

Summary

• Michael Rutz, President of Sterigenics at Sotera Health Co, filed a Form 4 detailing changes in beneficial ownership.
• On March 2, 2025, shares of common stock were withheld to cover tax obligations upon the vesting of RSUs at a price of $12.47 per share.
• Specifically, 3,687 shares were withheld related to RSUs granted on March 2, 2022, 4,198 shares related to RSUs granted on March 6, 2023, and 5,399 shares related to RSUs granted on March 4, 2024.
• On March 3, 2025, Rutz was granted 48,579 RSUs.
• As of March 3, 2025, Rutz beneficially owns 576,815 shares of common stock, including 80,901 RSUs and 495,914 shares of common stock.
• Of these, 472,715 shares are vested, and 22,199 shares remain subject to vesting conditions, vesting daily through May 13, 2025.
• Additionally, 24,289 performance-based RSUs were granted on March 3, 2025, subject to stock price-related performance conditions.
• The filing also references previously reported stock options with exercise prices of $14.59, $17.59, $20.03, and $23.

Sentiment

Score: 6

Explanation: The document is a neutral regulatory filing. The granting of RSUs and performance-based RSUs can be seen as a positive sign of alignment with shareholders, but the tax withholding is a routine event.

Positives

• The granting of RSUs and performance-based RSUs to a key executive suggests a continued alignment of interests with shareholders.
• The vesting schedule of the new RSUs provides an incentive for continued service and performance.

Future Outlook

The RSUs granted on March 3, 2025, will vest annually starting March 3, 2026, subject to continued service and, in the case of performance-based RSUs, stock price performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and alignment with shareholder interests.

Comparison to Industry Standards

• Executive compensation packages, including RSUs and stock options, are common in publicly traded companies like Sotera Health Co to incentivize performance and retain key personnel.
• The vesting schedules and performance-based conditions are typical features designed to align executive interests with long-term shareholder value.
• Comparing the size and structure of Rutz's equity grants to those of executives at comparable companies in the healthcare sterilization and lab testing industry (e.g., Steris, Danaher) would provide further context on the competitiveness and appropriateness of his compensation.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign of management's commitment to the company's long-term success.
• Employees may be motivated by the potential for similar equity-based compensation.

Key Dates